A revolutionary mRNA cancer vaccine developed by scientists at the University of Florida could reshape the future of cancer treatment. Unlike traditional therapies that rely on chemotherapy, radiation, or surgery, this vaccine teaches the body’s own immune system to identify and destroy cancer cells on its own.
What sets this vaccine apart is its ability to activate type-I interferons—immune system signals that sound the alarm and trigger a powerful response against cancer. Even more impressive is the phenomenon known as "epitope spreading," where the immune system begins attacking multiple targets within the tumor, delivering a comprehensive strike that stubborn cancers cannot easily escape.
The vaccine uses mRNA to instruct cancer cells to produce the PD-L1 protein, making hidden tumors visible to immune defenses. In mouse trials, this resulted in total tumor elimination and long-lasting protection from recurrence. Immune responses generated against one type of tumor were also effective against others, hinting at the future possibility of a universal cancer vaccine.
This game-changing discovery brings new hope to patients worldwide, especially those with aggressive or treatment-resistant cancers. It may mark the start of a new era in personalised, side-effect-free cancer therapy.
Sem comentários:
Enviar um comentário